TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Cannabis Stocks
2 Risky Stocks That Could Send Your $100,000 Investment to $0
Cannabis Stocks
My Biggest Investing Regret in 2025 Was Buying This Stock
Cannabis Stocks
2 Popular Stocks That Could Wipe Out a $100,000 Nest Egg
Investing
3 Risky Stocks That Could Send Your $100,000 Investment to $0
Cannabis Stocks
Here’s Why I Wouldn’t Touch Canopy Growth Stock With a 10-Foot Pole
Dividend Stocks
3 Overhyped Stocks to Leave Behind in the New Year
Cannabis Stocks
2 Stocks That Could Turn $100,000 Into $0 Faster Than You Think
Cannabis Stocks
Will Canopy Growth Keep the Losing Streak Going in 2026?
Cannabis Stocks
Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?
Cannabis Stocks
Have Cannabis Stocks Totally Gone Up in Smoke?
Cannabis Stocks
Canopy Growth Stock Jumped 30% Last Month: What’s Going on?